Contrast-enhanced ultrasound (CEUS) is a valuable bedside imaging technique that enables both qualitative and quantitative assessment of cerebral perfusion. In neonates and infants whose fontanelles remain open, the technique is particularly useful as it delineates cerebral pathology with high soft-tissue contrast. The technique has the potential to be a valuable alternative to computed tomography (CT) or magnetic resonance imaging (MRI) in critically ill neonates and infants in need of bedside imaging. While further studies are needed to validate the technique, preliminary data in this regard appear promising. This review introduces the current understanding and future potential of brain CEUS.
Introduction
In comparison to conventional brain ultrasound (US), brain contrast-enhanced US (CEUS) offers additional information on cerebral perfusion [1, 2] . Because perfusion changes accompany brain injury, CEUS can also detect areas of brain injury. Ideally, brain CEUS should follow the standard of care US to evaluate anatomical detail before contrast administration. Microbubbles remain intravascular, in the absence of compromised blood-brain barrier, thereby creating high signal in areas containing large and small intracranial vessels [1, 2] . This permits detection of perfusion abnormalities associated with ischemia, hemorrhage, focal lesions, infection and intracranial shunts. Its ability to assess cerebral perfusion serially at bedside serves as a major advantage in neonates and infants, whose transport to the magnetic resonance imaging (MRI) suite is inconvenient due to support devices, the critical nature of their illness, the availability of support staff and high cost.
A major advantage of brain CEUS is the ability to quantify cerebral perfusion based on the microbubble flow dynamics [1, 2] . As the microbubbles flow into a region of interest in the brain, the intensity in decibels of the region of interest changes during the wash-in and wash-out phases from which cerebral perfusion can be quantified. It is based on this intensity change that a time-intensity curve can be generated and various quantification parameters derived. Figure 1 depicts a representative microbubble wash-in graph with a curve fitted to the graph and derivation of the associated quantification parameters. From the curve, standardized CEUS perfusion metrics including peak enhancement, time-to-peak, rise time, wash-in slope or perfusion, wash-in area under the curve and perfusion index can be evaluated. Peak enhancement refers to intensity (decibels) at peak enhancement, time-to-peak is the time from the start of cine recording to peak enhancement, rise time is the time from the start of the rise in wash-in curve to peak enhancement, wash-in under the curve is the total area under the curve during rise time, and finally perfusion index refers to wash-in under the curve over rise time.
Evaluating the evolution of cerebral perfusion in the setting of injury is valuable for prognostication and guidance of therapeutic intervention. A study of infants with hypoxic ischemic injury applied Doppler US to perform serial cerebral blood flow measurements and showed that in severe hypoxic ischemic injury as compared to mild or moderate hypoxic ischemic injury, higher reperfusion was seen at the immediate postinjury period as well as 2 weeks later [3] . Post-ischemic hyperperfusion to the basal ganglia and thalamus has been suggested to increase the vulnerability of metabolically active regions [4, 5] . A previous study with positron emission tomography (PET) performed in infants with hypoxic ischemic injury showed that decreased cerebral uptake at 2 weeks correlated with poor outcome at 2 years [6] . The studies overall suggest that not only hypoperfusion, but also continued or exaggerated post-ischemic hyperperfusion, may lead to irreversible brain damage. A better understanding of the relation between the evolution of cerebral perfusion and clinical outcome will therefore be important in developing therapies targeted to minimizing reperfusion injury, promoting vascular remodeling and/or maintaining critical perfusion pressure.
Practice guidelines
Institutional/food and drug administration approval Application of CEUS to evaluate intracranial pathology remains an off-label indication in the United States. This is mainly due to the paucity of published clinical reports and safety data. After Kastler et al. [7] from Europe reported a small cohort of neonates and infants evaluated for intracranial pathology with CEUS, Hwang et al. [1, 2] introduced feasibility brain CEUS studies on neonates and infants in the United States. Given the promise of brain CEUS in the diagnosis of various intracranial pathology not limited to ischemia and the absence of documented adverse events, brain CEUS is gaining more interest. With clinical studies, an off-label consent form may be used to inform the parent of a child of the technique and safety concerns. With research studies, institutional review board and/or United States Food and Drug Adminstration (FDA) approval for a New Investigational Drug study will be needed to ensure the optimal documentation of the procedures and results for future benefit.
Acoustic power (mechanical index)
There are important safety measures to be aware of in conducting clinical brain CEUS. The minimum safety requirement is to abide by the acoustic power or mechanical index (MI, unitless) of <1.9, which is established by the FDA to be the maximum threshold for diagnostic imaging. Typical MI used for CEUS imaging is much lower at 0.05-0.4, and the commercially available scanners usually have MI set at less than 0.1 for the CEUS setting. The absence of bubble growth below the MI value of 0.5 has been reported previously [8] . Moreover, frequent usage of a destruction pulse (MI of 1.0 or higher), which is introduced either by an option on the scanner by switching to a gray-scale mode, will need to be avoided until safety data are available in regard to the effects of high MI on the integrity of blood-brain barrier. The destructionreplenishment method utilizes the induced burst of microbubbles in a region of interest to assess reperfusion dynamics without the need for reinjection and can be a useful tool, but its application in the brains of neonates and infants should not be used until there is reasonable confidence that bubble destruction does not result in injury to the blood-brain barrier.
Injection dosage
While the contrast dosage for application in neonatal and infant brains is not established through a carefully designed study, Hwang et al. [1, 2] have used the FDA-recommended Lumason (Bracco Diagnostics Inc., Monroe Township, NJ) dosage of 0.03 cc/kg for the pediatric population with optimal image quality. To keep the dosage constant across scanners, subjects and institutions, an adequate understanding of microbubble resonant frequency and US settings will be needed. The US parameters that can be adjusted to optimize microbubble signal include MI, gain, frequency and depth. Depending on the scanner type and probe selection, these settings will need to be adjusted to accommodate for the same injection dosage and image quality. For instance, one scanner type may have varying contrast settings with different transmit frequencies; in such cases, the US settings will have to be adjusted to account for microbubble resonant frequency of 2-3 MHz. If the transmit frequency or probe frequency is much higher at 6-7 MHz, there will be increased attenuation and decreased microbubble oscillation as a result. To account for the loss of microbubble signal, acoustic power may be increased within the limits of safety standards, for instance.
Number of injections
As with other CEUS exams in pediatric and adult populations, brain CEUS in neonates and infants can involve up to two injections per scan. While the second injection may not be necessary, it is beneficial in the early stages of clinical application to confirm reproducibility of the exam and validate any potential abnormality seen during the first injection. Although the rate of wash-out varies depending on the disease state, with normal subjects demonstrating quicker wash-out than affected subjects, it is advised that the second injection be performed after natural wash-out rather than employing a destruction pulse to expedite the exam. Based on the preliminary experience, microbubbles reside in the intracranial vasculature for 6-8 min after injection in normal subjects and can reside for up to 30 min in patients near brain death [2] . Note that not only the wash-in phase but also the wash-out phase can provide important clues to the disease state and will need to be studied.
Injection parameters
Injection of microbubbles requires proper knowledge of the effects of needle gauge, rate of injection and site of injection on the interpretation of brain CEUS exams. In neonates and infants, the needle gauge is often smaller in children, with peripheral intravenous (IV) lines in the scalp or the foot, and injection should be performed at a slow rate to minimize microbubble destruction within the needle [9, 10] . If the peripheral IV line is in the foot, the time from injection to perfusion of intracranial vasculature is increased thereby affecting the time-to-peak parameter. In the presence of a long intravascular line, moreover, an appropriate saline flush to account for the length of the line should be adopted to adequately clear the microbubbles within the line. In the presence of IV in-line filters, microbubbles should be injected above the filters to avoid entrapment. Central lines can be used with sterile technique and should not interfere with the exam interpretation.
Clinical protocol
Brain CEUS requires the acquisition of both dynamic and static images of the brain in coronal and sagittal planes during the microbubble wash-in and wash-out phases. The anterior fontanelle is initially used for acoustic window, as this allows delineation of the near entirety of the brain during coronal and sagittal scans. Depending on the operator's experience, posterior fontanelle and transmastoid views may be further obtained. Before contrast injection, gray-scale images of the brain should be obtained per the clinical protocol. The mid-coronal scan plane including the bilateral basal ganglia and frontal horns is then selected for the first contrast injection (Fig. 2) . The reason for this slice selection is both to standardize of the initial scan plane for data analysis purposes and to screen for potential injury to both deep and superficial gray-white matter. The contrast timer should begin at the time of contrast injection. The US probe is held over the anterior fontanelle in a stable position during a 20-s cine clip of microbubble wash-in into the mid-coronal scan plane. In normal subjects, wash-out may begin toward the end of the 20-s cine clip, but this may vary across individuals depending on the injection site, injection rate and hemodynamic status. Afterward, anterior to posterior then posterior to anterior sweeps through the brain in coronal plane are performed to screen for potential perfusion abnormality in the remainder of the brain. Immediately following the coronal sweeps, sagittal sweeps are performed to assess for perfusion abnormality potentially missed or less evident during the coronal sweep. The delayed wash-out phase is then recorded with intermittent 30-s cine clips, and this recording may occur for a longer period in affected cases. Static images can be retrospectively extracted from the cine clips to save time.
Clinical applications

Hypoxic ischemic injury
Brain CEUS enables qualitative and quantitative detection and monitoring of hypoxic ischemic injury. There is a paucity of studies in this regard, although emerging evidence demonstrates promise [1, 2] . Distinct patterns of perfusion abnormalities associated with hypoxic ischemic injury include 1) focal, 2) multifocal, and 3) diffuse and/or symmetrical (Fig. 3) . Qualitatively, detecting perfusion abnormality types 1 and 2 is easier than type 3 [1] . For accurate and reliable detection of diffuse and/or symmetrical perfusion abnormalities accounting for technical differences, a standardized quantitative method will be needed. The main challenge behind establishing a quantitative method lies in the difficulty of acquiring the agedependent normative data. While brain CEUS is a relatively safe technique, the contrast administration itself is associated with minimal risk, which negates the possibility of recruiting normal subjects for the sole purpose of amassing the normative data. The reasonable approach would be to build a database of normal subjects based on those screened but who turned out to have normal clinical and imaging findings, with the latter confirmed with gold standard methods such as computed tomography (CT) or MRI.
While the quantitative method needs further validation, Hwang et al. [1, 2] suggested several potential approaches for future studies. For focal and multifocal perfusion abnormalities, quantitative parameters of the affected region(s) can be compared to that of the contralateral unaffected region(s) as internal control or to the normative data, if available. For diffuse and/or symmetrical perfusion abnormalities, establishing either the normal gray-white matter ratio or gray nuclei to cortex ratio based on the normative data is necessary. Not only is the perfusion differentially affected in the gray versus white matter, injury can also be isolated to the gray or white matter [12] [13] [14] . Gray-white matter ratio is obtained by placing the region of interest in the gray and white matter, respectively. Central gray nuclei to cortex ratio is the perfusion ratio obtained of the deep gray nuclei (basal ganglia and thalami) to the remainder of the cortex (Fig. 4) . Note that in normal neonates and infants, there is relative hyperperfusion to the basal ganglia and the thalamus as compared to the cerebral cortex [15] . This ratio is especially valuable in detecting either the central or peripheral pattern of hypoxic ischemic injury. Normal neonates and infants would demonstrate a gray nuclei to cortex ratio greater than 1, but significantly greater than this would be seen in central pattern of hypoxic ischemic injury. In the presence of focal or symmetrical peripheral pattern of injury, the central gray nuclei to cortex ratio would be less than 1 and indicative of brain injury (Hwang M., Sridharan A., Darge K., et al., unpublished data). Depending on the size and types of brain injury, the gray-white matter ratio and/or gray nuclei to cortex ratio would be altered and quantitatively detected. Note that such ratios can be obtained of the various perfusion parameters of the wash-in and wash-out time intensity curve, for comparison between normal and affected patients. 
Intracranial hemorrhage
While in the beginning stages of hemorrhage, cerebral perfusion is protected by reflex mechanisms, further blood loss can lead to metabolic stress, global hypoperfusion and neuronal death. It is difficult to discern on gray-scale US whether the cerebral perfusion around the hemorrhage or remainder of the brain is also at risk. In this regard, brain CEUS helps delineate the extent of cerebral perfusion compromise in the setting of intracranial hemorrhage and accurately delineates the hemorrhagic core itself. Figure 5 demonstrates a case in which cerebral perfusion is preserved around the hemorrhage, and the region of heterogeneous hypoperfusion on brain CEUS corresponds to the hyperechogenic hemorrhagic core as seen on the gray-scale US.
Focal lesions
Various intracranial lesions, including brain tumors, can be evaluated with brain CEUS to assess dynamic perfusion parameters that are of both diagnostic and prognostic value [16, 17] . Vascular malformations, including arteriovenous malformation, can be assessed for degree of shunting as well as blood flow and volume with brain CEUS, pre-and postendovascular coiling if applicable to assess for treatment response and residual flow. Note that the performance of brain 
Hydrocephalus
Post-hemorrhagic hydrocephalus is a major complication of intraventricular hemorrhage, and the risk of intraventricular hemorrhage is very high in premature babies [18] . In order to reduce long-term cognitive and motor disability of premature infants with post-hemorrhagic hydrocephalus [19] [20] [21] [22] , timely decompression of hydrocephalus is needed. Exactly when to place a ventricular shunt for decompression of increased intracranial pressure (ICP) remains a clinical dilemma for neurosurgeons, however. Increase in ventricular size as detected by bedside gray-scale US or ultra-fast MRI is an important decision-making factor in shunt placement, despite Fig. 4 Central gray nuclei to cortex ratio in a 1-month-old boy (a, b) and a 14-day-old boy (c). The central gray nuclei (basal ganglia and thalami) (red) and cortex (areas excluding central gray nuclei) (yellow) are outlined on a mid-coronal contrast-enhanced ultrasound. The central gray nuclei to cortex ratio equals perfusion in central gray nuclei (red) over perfusion in cortex (yellow). Parts (a) and (b) demonstrate a representative case with the normally seen hyperperfusion to the central gray nuclei, with (a) obtained at 10 seconds after microbubble administration and (b) obtained at 15 seconds after administration at peak enhancement. Part (c) demonstrates a hypoxic ischemic injury case in which the normally seen central gray nuclei to cortex ratio greater than 1 is absent because of diffuse hyperperfusion to the brain in the immediate post injury setting. In this case, the central gray nuclei to cortex ratio is noted to be approximately equal to 1. The image was obtained at 18 seconds after microbubble administration at peak enhancement. Note that all the images were obtained with EPIQ scanner (Philips Healthcare, Bothell, WA) and C5-1 transducer with settings of 12 Hz and mechanical index of 0.06 the lack of reliable association between ventricular size and abnormal ICP [23] [24] [25] [26] . Applying brain CEUS may permit an improved understanding of perfusion changes that occur with the evolution of post-hemorrhagic hydrocephalus and optimal timing of shunting in consideration of long-term cognition and motor function. Fig. 6 Generation of ultrasound perfusion maps from contrast-enhanced ultrasound (CEUS). a-e CEUS of a 10-month-old girl status post multiple cardiac arrests and extracorporeal membrane oxygenation. Dynamic CEUS images from time 0 to 44 s demonstrate abnormally avid perfusion to the cortical and subcortical regions of the cerebral cortex as well as the central gray nuclei, resulting in abnormal gray nuclei to cortex ratio. Higher peak intensity and area under the curve, as well as delayed wash-out, were seen in both regions as compared to normal subjects. f-h US perfusion maps reconstructed from the original CEUS. Black denotes no perfusion, blue low perfusion, yellow/green moderate perfusion, and red high perfusion relative to the remainder of the brain. f The map of wash-in or perfusion (PER) shows fast rate of wash-in (red) in the cortical/subcortical regions as well as the central gray nuclei. g The map of peak enhancement (PE) shows accentuation of increased flow in the cortical/subcortical regions greater than the central gray nuclei. h The map of wash-in area under the curve (WiAUC) or wash-in under the curve similarly demonstrates increased flow in the cortical/subcortical regions and central gray nuclei. A coronal T2-weighted MR sequence (i) in the same patient 4 months following the CEUS scan demonstrates interval development of marked encephalomalacia and ventriculomegaly due to severe hypoxic ischemic injury. Adapted from Shin et al. [11] with permission. a-e EPIQ scanner (Philips Healthcare, Bothell, WA) and C9-2 transducer with settings of 7 Hz and mechanical index of 0.06
Current limitations and future directions
One of the major limitations in advancing brain CEUS to the clinical setting is the paucity of data and off-label usage. With further experience and validation of quantitative techniques, brain CEUS will be of significant value in the clinical setting by serving as a safe alternative to CT or MRI in neonates and infants. Another limitation is due to the 2-D nature of the exam. The entirety of wash-in and wash-out parameters cannot be obtained of the 3-D brain; rather, sweeps through the brain are acquired for visual screening of perfusion abnormality. The mid-coronal section through the brain chosen for cine clip can only be quantitatively evaluated for various wash-in parameters. It is expected, however, that in the next few years there will be increased interest in developing brain CEUS compatible 3-D US probes that can help assess whole-brain perfusion for quantification similar to CT or MRI perfusion techniques. Note also that the artifacts in the superior near field adjacent to the cranium in the provided figures are largely due to the absence of a pediatric-specific brain contrast US probe. The US probe used to generate the figures in this paper is designed for imaging the adult abdomen and is much larger than the neonatal anterior fontanelle used as the acoustic window. The presence of such artifacts can interfere with accurate quantification of brain perfusion. A pediatric-specific brain contrast US probe has recently been introduced, however, which will minimize this concern.
Moreover, the performance and interpretation of brain CEUS exams would require proper training for technologists and radiologists. The quantification method can also be daunting at first, as radiologists are used to qualitative rather than quantitative interpretation of brain US. The region of interestbased quantification can be done conveniently on the scanner, although the generation of US perfusion maps with minimal artifactual contribution requires advanced post-processing software such as Matlab (Mathworks, Natick, MA). In the future, it may be that quantification methods such as the central gray matter to cortex ratio can be built into software that can then instantaneously detect brain injury. Since the quantitative method needs further research and validation, radiologists in the meantime would need to first learn to subjectively interpret brain CEUS exams and be able to detect areas of perfusion abnormality.
In order to establish brain CEUS as a clinically valuable technique, it will be necessary for future exams to compare brain CEUS parameters with that of gold standard exams such as CT or MRI. Hwang M., Sridharan A., Darge K., et al. (unpublished data) have generated US perfusion maps and demonstrated their comparability to MRI perfusion maps upon qualitative assessment. US perfusion maps can be generated of the wash-in slope or perfusion, peak enhancement and wash-in area under the curve, representing the rate of wash-in, peak intensity and blood volume, respectively (Fig. 6 ). As in CT or MRI, the quantifiable perfusion maps will permit better understanding of the extent of ischemia and tissue at risk in the setting of brain injury. Instantaneous generation of these maps in the presence of normative data will be tremendously helpful in promoting bedside diagnosis and intervention.
Conclusion
Brain CEUS is a potentially valuable technique that enables bedside detection of cerebral pathology. Given the quantifiable nature of the technique, both accurate diagnosis and serial monitoring of perfusion abnormalities are feasible. Given the novelty of its application in the neonate and infant population, more updates are expected in the next few years. Advancements will likely improve the current clinical algorithm and its diagnostic utility in this patient population.
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